ViViRA
ViViRA provides a digital health platform offering daily guided training, weekly progress controls, and monthly movement tests for patients and doctors.
Classification
Profile
Funding
Compliance
Medical device app reducing non-specific back pain via guided, guideline-compliant exercises for home use.
DACH patients with non-specific back pain or degenerative spinal conditions, accessed via prescription and statutory health insurance.
Budget-neutral provision via statutory health insurance; users activate the app using a 16-digit code provided by their insurer.
Distribution through healthcare providers issuing prescriptions to patients, who then obtain activation codes from their health insurance.
Collaborates with German health insurance companies (Krankenkassen) for prescription fulfillment and cost coverage.
R&D for medical device software compliance, clinical validation, and administrative support for insurance code distribution.
Digitally Therapeutic Agent (DiGA) certification, clinical evidence for efficacy, and the proprietary ViViRA exercise platform.
Maintaining medical device software compliance, updating exercise content based on guidelines, and managing customer support for activation.
Prescription-based acquisition; post-activation support via email and phone for technical assistance with code usage.
Competes in the DiGA register as a therapy for back pain; differentiates through guideline-compliant, medically prescribed home training.
Manages chronic non-specific back pain and degenerative spinal conditions like osteoarthritis without requiring clinic visits.
- Expand to private-pay “wellness” tier - Offer premium modules (e.g., AI-based motion analysis, personalized coaching) to capture revenue
Maintaining DiGA status is essential; any regulatory change could erode the primary revenue stream · Diversifying revenue (private-pay and data services) will hedge against potential reimbursement pressure · Investing in sensor integration can create a defensible technology moat, supporting higher pricing and deeper clinical outcomes, which in tu
- Regulatory validation - Being listed as a DiGA gives ViViRA a legally recognized health-benefit claim, which is rare among health-tech st
No investors recorded yet.